Urgent.News

the world's headlines, one feed

Finance & Markets

Many bought this stock to play the GLP-1 boom, but it has bigger opportunities to boost its share price

Instead of betting on which single pharmaceutical company wins a drug race, this company benefits as the industry grows by supplying the proprietary packaging.

We haven't written up this one. CNBC has the full story — the link below goes straight to it.

Read the original at cnbc.com →

More in Finance & Markets